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Background: Hantavirus nucleocapsid (N) protein is a multifunctional viral macromolecule involved in multiple
stages of the viral replication cycle. The intracellular trafficking of N protein during virus assembly remains unclear.
Methods: We used N protein-specific intracellular expressed antibodies to track the localization and distribution of
Hantaan virus and Seoul virus N protein. The N protein-specific antibody single-chain variable antibody fragments
(scFvs), which bind an N-terminal linear epitope (L13F3) and C-terminal conformational domain (H34), were
intracellularly expressed in the endoplasmic reticulum (ER) by fusion of the SEKDEL retention signal peptide at the
carboxyl terminus, and in the cytoplasm (Cyto) by deletion of the ER membrane target signal peptide. Stable Vero-
E6 cell lines expressing intracellular scFvs were either infected with hantavirus or transfected with an N protein
expression plasmid; virus replication and N protein intracellular localization were determined.
Result: N protein co-localized with scFvs in the ER and cytoplasm with or without viral membrane glycoproteins.
Hantavirus replication was inhibited in both the scFvs-ER- and scFvs-Cyto-expressing stable cell lines.
Conclusion: N protein may be expressed in the ER retention signal peptide of KDEL circulating region (ER/cis-
Golgi) without the assistance of G protein, and so expression of N protein in both the cytoplasm and within the
ER/cis-Golgi plays an important role in virus replication.
1. Background
Hantaviruses are members of the Bunyaviridae family,
which contain three negative-sense, single-stranded
RNA genome segments designated large (L), medium
(M), and small (S) [1]. The S, M, and L segments
encode the nucleocapsid protein (N), glycoproteins (Gn
and Gc), and L protein (an RNA-dependent RNA poly-
merase), respectively. Hantaviruses do not have matrix
proteins, but the N protein has been proposed to play a
key role in virus assembly [2]. N protein is expressed in
the cytoplasm, viral glycoproteins are co-translated in
the endoplasmic reticulum (ER), once cleaved, Gn and
Gc undergo glycosylation, folding, and heterodimeriza-
tion in the Golgi complex, where they are retained and
accumulate. For assembly to occur, N as well as Gn and
Gc, must move to the same intracellular location. After
interaction of N protein with viral RNA and subsequent
assembly, ribonucleoprotein (RNP) is targeted to the
Golgi complex by specific recognition of the cytoplasmic
tail of Gn and Gc protein [3], the interaction of Gn pro-
tein cytoplasmic tail and the middle domain of the N
protein was suggested to play essential role to direct
RNPs to the site of the virus assembly [4] and the com-
plete hetero-oligomeric (Gn-Gc) spike complex of han-
taviruses might mediates the packaging of RNP into
virions [5].
N protein has an intrinsic RNA chaperone activity,
which is important for encapsidation and genome repli-
cation [6,7]. The RNA-binding domain of N protein is
situated within a central conserved region between resi-
dues 175 and 217 [8]. The 141 residues proximal to the
C-terminal are required for Golgi localization [9]. Both
N- and C-terminal regions have been implicated in
homotypic N protein interaction, and putative coiled-
coil motifs in the N-terminal region of N protein have
been proposed to facilitate trimerization [10-12]. N was
not observed in the Golgi so far, but it could be
observed to surround the Golgi after infection [13,9]
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Golgi intermediate compartment (ERGIC), prior to its
movement to the Golgi compartment, and an intact
ERGIC are necessary for viral replication [14]. However,
the impact of N protein intracellular trafficking on the
cell and its effect on virus replication remain unclear.
We used intracellular expression of anti-Hantaan virus
(HTNV) and Seoul virus (SEOV) N protein N-terminal-
and C-terminal-specific antibodies, respectively, to block
or knock down N protein function at targeted sites,
with or without co-expressed membrane glycoproteins,
and assess the effect on virus replication and N protein
intracellular trafficking. Our data showed that N protein
co-localized with both cytoplasm and ER-retarded anti-
bodies either with or without the help of G protein and
virus replication was inhibited by related intracellular
antibodies. These data suggest, therefore, that presenta-
tion of N protein both in the cytoplasm and within the
ER/cis-Golgi plays an important role in hantavirus
replication.
2. Materials and methods
2.1. Cells and antibodies
Vero-E6 cells, COS-7 cells, and a mouse hybridoma cell
line L13F3 expressing mouse mAb binding to N protein
of HTNV and SEOV (which targeted at a N-terminus
epitope [15]) were cultured in Dulbecco’sm o d i f i e d
Eagle’s medium (DMEM) supplemented with fetal calf
serum (FCS; 10% v/v), penicillin (100 IU/ml), streptomy-
cin (100 μg/ml), and L-glutamine complete (4.5 mM).
The phage display-derived human Fab H34, which recog-
nizes the HTNV N protein C-terminus conformational
domain, was produced in our laboratory [16].
2.2. Plasmids
To construct single-chain fragment variable antibody
fragments (ScFvs) specific for hantaviruses N protein,
mRNA was isolated from ~1 × 10
6 L13F3 hybridoma
cells using Trizol reagent (Invitrogen, Carlsbad, CA,
U S A ) .T h ef i r s tc D N As t r a n dw a ss y n t h e s i z e du s i n g
SuperScript™reverse transcriptase (Invitrogen) according
to the manufacturer’s directions. L13F3 heavy chain
(VH) variable region gene fragments were amplified
using the forward primer 5’-GAATAGGCCATGGCG-
GAGGTCCAGCTGCAGGAGTCTGGGGGAGGCTTA
G-3’ and the reverse primer 5’-GGCCAGTGGA-
TAAAGCTTTGGGGGTGTCGTTTTGGC-3’. NcoIa n d
HindIII restriction sites were introduced at the 5’-a n d
3’-ends, respectively, of the VH gene using synthetic oli-
gonucleotides. The L13F3 V gene was PCR-amplified
using a forward primer with the nucleotide sequence 5’-
TACAGGATCCACGCGTAGACATTGTGATGACC-
CAGTCT-3’ and a reverse primer of sequence 5’-TGA-
CAAGCTTGCGGCCGCGGATACAGTTGGTGCAGC-
ATC-3’, containing MluI and NotI sites, respectively.
PCR products were subsequently inserted into plasmid
pOPE-101-215 [17] between the restriction sites. The
resulting plasmid was named pOPE-L13F3-scFv. As
above, the H34-scFv-expressing plasmid pOPE-H34-scFv
was constructed as follows: the H34 VH gene was
amplified from the H34 Fab fragment using synthetic
oligonucleotides with sequences 5’-GAATAGGCCAT-
GGCGGAGGTGCAGCTGGAGTCT-3’ and 5’-CAGT-
CAAGCTTTGATGAGACGGATACC-3’,a n dNcoIa n d
HindIII restriction sites were introduced at the 5’-a n d
3’-termini, respectively. The H34 VK gene was amplified
using a forward primer with the nucleotide sequence 5’-
TACAGGATCCACGCGTAGAAATTGTGTTGACG-
CAGTCTCCA-3’ and the reverse primer 5’-TGA-
CAAGCTTGCGGCCGCGAAGACAGATGGTGCAGC-
CACAGTTCGTCTG A-3’,a n dM l u Ia n dN o t I
restriction sites were introduced at the 5’-a n d3 ’-ends,
respectively. PCR products were cloned into the plasmid
pOPE-101-215.
To construct plasmids expressing intracellular scFvs in
mammalian cells, the scFv gene (encoding a 6-histidine
tag at the 3’-terminus) was PCR-amplified using the for-
ward primers scFv-L13F3F-BssHII 5’-GGCGCGCA-
CTCCGAGGTCCAGCTGCAGGAGTCTG-3’,s c F v -
H34F-BssHII 5’-GGCGCGCACTCCGAGGTGCAGC-
TGGAGTCT-3’ and the reverse primer scFv-R-XhoI 5’-
CTCGAGATGATGATGGTGATGATGGGATAG-3’
from plasmids pOPE-L13F3-scFv and pOPE-H34-scFv,
respectively. Amplified fragments were cloned into pEF/
myc/ER (Invitrogen) between the BssHII and XhoI
restriction sites, producing the intracellular antibody
expressing plasmids L13F3-scFv-ER and H34-scFv-ER.
For the construction of plasmids L13F3-scFv-CYTO and
H34-scFv-CYTO expressing cytoplasmic scFv, the scFv
gene was prepared using NcoI/NotI from plasmids
pOPE-L13F3-scFv and pOPE-H34-scFv and inserted
into the pEF/myc/cyto vector (Invitrogen) between the
NcoI and NotI restriction sites.
Plasmid pEF-N76118 was generated by amplifying the
HTNV strain 76-118 N protein coding sequence using
primers carrying adapters, and then cloned into pEF/
myc/cyto and digestion with NcoI and XbaI.
2.3. Transfection
The HTNV 76-118 N protein mammalian expression
plasmid pEF-N76118 and intracellular antibody-expres-
sing plasmids L13F3-scFv-ER, H34-scFv-ER, L13F3-
scFv-CYTO, and H34-scFv-CYTO were transiently or
stably transfected into eukaryotic cells. Plasmid DNA (3
μgo r1μg) was coated onto the bottom of each well of
a 6- or 24-well plate, respectively, using Lipofectamine
2000 (Invitrogen) according to the manufacturer’s
instructions. COS-7 cells were co-transfected with pEF-
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Cells were harvested 48 h after transfection. To generate
cell lines for stable expression of antibodies, Vero E6
cells were transfected with scFv-expressing plasmids;
cultures supplemented with G418 (500 μg/ml) were
started 48 h after transfection. Mock-transfected cells
died within 7 days in selective medium. Clones were iso-
lated using the limited dilution method, dispensed into
96-well plates, and kept under selection pressure (G418;
500 μg/ml) for 14 days before reverting to normal cul-
ture medium. In this way, the antibody-expressing,
stable Vero-E6 cell lines L13F3-scFv-ER-E6, H34-scFv-
ER-E6, L13F3-scFv-CYTO-E6, and H34-scFv-CYTO-E6
were obtained.
2.4. Immunoblot assay
Immunoblots were used to confirm specificity of the
recombinant scFvs. Routinely concentrated HTNV strain
76-118 and SEOV strain L99 prepared from Vero E6
cells (8 μl) were mixed with 5× SDS-PAGE Laemmli
sample buffer [2 μl; 60 mM Tris-HCl (pH 6.8), 2% (w/v)
SDS, 10% (v/v) glycerol, 5% (v/v) b-mercaptoethanol,
and 0.01% (w/v) bromophenol blue]. Following denatur-
ing at 95°C for 10 min, proteins were resolved on 12%
(w/v) SDS-PAGE gels and electroblotted onto PVDF
membranes. These membranes were rinsed with phos-
phate-buffered saline (PBS), blocked using 5% (w/v)
skim milk powder in PBS (PBS-M) for 30 min, and
probed with recombinant L13F3-scFv and H34-scFv (10
ml; 1 μg / m l )f r o mX L 1 - B l u ei nP B S - Ma tr o o mt e m -
perature (RT) for 2 h. After washing, the membrane was
incubated in mouse anti-penta-His monoclonal antibody
(1:1000 in PBS-M) for 1 h at RT. Membranes were then
washed and incubated with goat anti-mouse IgG gamma
chain-specific AP-conjugated antibody (1:1000 dilution
in PBS-M) (Sigma) for 1 h at RT. After washing, mem-
branes were developed in BCIP/NBT (Roth, Karlsruhe,
Germany) substrate solution. All washes were performed
thrice for 5 min each in 0.05% (v/v) PBS-T.
2.5. Enzyme-linked immunosorbent assay (ELISA)
To determine the concentration of viral particles in cul-
ture supernatants, group-specific L13F3 mouse anti-N
mAb was coated onto 96-well microtiter plates over-
night at 4°C. Coated plates were blocked with 5% (w/v)
skimmed milk in PBS, and serial dilutions of detergent-
treated culture supernatants were added. After washing,
bound viral particles were detected by horseradish per-
oxidase-conjugated L13F3 mAb diluted 1:1000 in PBS-
T. After washing three times with PBS-T, TMB peroxi-
dase substrate [100 μl; dimethylformamide and hydro-
gen peroxide (H2O2)] was added and developed at RT
for ~30 min. The reaction was stopped by adding
H2SO4 (100 μl; 1 N). A450 (reference 620 nm) was read
using a DTX 880 multi-mode detector (Beckman Coul-
ter, Fullerton, CA, USA). The cutoff value was three
standard deviations above the mean absorbance of the
negative control wells.
2.6. Virus infection
HTNV strain 76-118 and SEOV strain L99 were propa-
gated on Vero E6 cells. Cell cultures were harvested at
10 days postinfection; cell debris was removed by centri-
fugation at 4000 × g and samples stored in 1-ml aliquots
at -80°C. Vero E6 cells and the intracellular antibody-
expressing Vero-E6 cell lines L13F3-scFv-ER-E6, H34-
scFv-ER-E6, L13F3-scFv-CYTO-E6, and H34-scFv-
CYTO-E6 were cultured in T25 flasks to 85% conflu-
ence; cells were washed twice with pre-warmed serum-
free DMEM and virus 76-118 and L99 were loaded at a
multiplicity of infection (MOI) level of 0.01. Cells were
then incubated at 37°C for 2 h. Cells were washed twice
with pre-warmed serum-free DMEM and maintained in
DMEM (5 ml) supplemented with 2% (v/v) FBS and
incubated at 37°C for 8 days. Cell culture supernatants
(1.0 ml) were collected each day after the third day post-
infection and an identical amount of fresh medium was
added. Viral antigen levels were assayed by ELISA using
the L13F3 mAb, as described above. Supernatant Hanta-
viruses titers were determined by serially diluting super-
natants of each virus stock and performing
quadruplicate infections on Vero-E6 cells in 96-well
plates. The TCID50 assay endpoint was determined on
day 10. Used medium was discarded and cells fixed in
80% (v/v) ice-cold acetone. Viral antigen were detected
by horseradish peroxidase conjugated L13F3 monoclonal
antibody, TMB peroxidase substrate (Dimethylforma-
mide and hydrogen peroxide) was added to develop
color. Absorbance at 450 nm (reference 620 nm) was
read with a DTX 880 multi-mode detector (Beckman
Coulter). The cut-off value was determined by the 3
times SD above the mean absorbance of the negative
control wells. And these were addressed at the part of
methods. The TCID50 value was calculated by the
method of Reed and Muench [18].
2.7. Immunofluorescence assay (IFA)
Specificity of the scFvs and intracellular distributions of
N protein and intracellular scFvs were determined by
indirect immunofluorescence assay (IFA). Hantaviruses-
infected Vero E6 cells, stably transfected Vero E6 cells,
or transiently transfected COS-7 cells were passaged
onto sterile coverslips in six-well plates overnight. Cells
were fixed by treatment with methanol for 10 min at
-20°C followed by acetone for 10 min at -20°C. To elim-
inate nonspecific binding, cells were pre-incubated with
PBS containing 5% (v/v) FCS for 30 min at RT in a
humidity chamber. Antibody dilutions of 1:50 for H34
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protein scFvs, and 1:200 for anti-penta-His mAb in PBS
containing 5% FCS were used. The first round of incu-
bation was carried out for 1 h at RT. For detection of
bound, purified anti-N protein scFvs, the secondary anti-
body (mouse anti-His tag mAb) was loaded and incu-
bated for 1 h. Antibodies were detected using either an
antihuman fluorescein isothiocyanate (FITC)-conjugated
secondary antibody or anti-mouse tetramethyl rhoda-
mine isothiocyanate (TRITC)-conjugated antibody. Cov-
erslips were washed in PBS, mounted on glass slides,
and imaged under a TCS NT confocal microscope
(Leica, Wetzlar, Germany).
2.8. His tag pull-down assay
About 5 × 10
7 HTNV-infected Vero E6 cells or the sta-
bly transfected cell lines L13F3-scFv-ER-E6, H34-scFv-
ER-E6, L13F3-scFv-CYTO-E6, and H34-scFv-CYTO-E6
were harvested by centrifugation. Pellets were lysed in 1
ml ice-cold extraction buffer [TBS, pH 7.5; containing
phenylmethylsulfonyl fluoride (1 mM), aprotinin (5 μg/
ml), leupeptin (5 μg/ml), and 1% (v/v) Triton X-100]
and gently rotated for 30 min. Samples were centrifuged
at 4°C and 12,000 rpm for 10 min to remove cell debris.
Ni-NTA His-bind resin (200 μl; Stratagene, La Jolla, CA,
USA) was added and cleared supernatants were incu-
bated at 4°C and 600 rpm in an Eppendorf thermomixer
for 2 h. The resin was then harvested by centrifugation
for 2 min at 4000 × g at 4°C and washed five times with
1 ml PBS and then five times with 1 ml PBS containing
imidazole (20 mM). Bound proteins were eluted from
the resin by incubation at 4°C in 500 μl PBS containing
500 mM imidazole. Pull-down elutes were stored at -80°
C in 100-μl aliquots. Aliquots were concentrated by
adding two volumes of ice-cold 100% ethanol and cen-
trifuged at 10,000 × g for 10 min; pellets were resus-
pended in 10 μld H 2O followed by analysis by SDS-
PAGE and immunoblotting with anti-penta-HIS (Qia-
gen, Hilden, Germany) and L13F3 N protein-specific
mAbs as described above.
3. Results
3.1. Intracellular expression of L13F3, H34 scFvs
To determine the binding activity of the recombinant
scFvs, immunoblot and IFA and ELISA analyses on
HTNV strain 76-118 and SEOV strain L99 were per-
formed. Figure 1 depicts an immunoblot using L13F3
(Figure 1A, left panel) and H34 scFvs (Figure 1A, right
panel) to probe viruses. The L13F3 scFv showed binding
to both strain 76-118 and L99; this finding was corrobo-
rated by IFA data (Figure 1B, panel 1 and 2). The H34
scFvs bound only to HTNV strain 76-118 (Figure 1B,
panel 3) and not SEOV stain L99 (Figure 1B, panel 4) in
the IFA test, and no binding was detected by
immunoblotting (Figure 1A, right panel). These data are
consistent with the binding activities of the L13F3 and
H34 parent antibodies.
Intracellular localization of scFvs was determined by
indirect immunofluorescence. As expected, L13F3 and
H34 scFvs-Cyto accumulated in the cytoplasm of trans-
fected cells (Figure 1C, 1 and 2), while L13F3 and H34
scFvs-ER yield a typical ER specific morphological fluor-
escence image (Figure 1C, 3 and 4).
3.2. N protein interacted with intracellular antibodies
in vivo
To investigate whether N protein interacts with intracel-
lular scFvs in vivo, a His-tag pull-down experiment was
performed. To exclude any nonspecific binding to His-
bind resin, 76-118 or L99 virus-infected Vero-E6 cells
were used as negative controls and normal Vero-E6
cells as blank controls. N protein and intracellular scFvs
were detected by SDS-PAGE analysis of the pull-down
eluates (Figure 2A, lanes 2, 4, and 6). However, scFv
Figure 1 Characterization of recombinant scFv antibodies.
A) Immunoblot analysis of recombinant scFvs. Concentrated 76-118
and L99 virus were separated on 12% SDS-PAGE and blotted on
PVDF membrane, parallel treated normal vero E6 cells culture
supernatant was used as negative control, the membrane was
incubated with prokaryotic produced and purified scFv, and mouse
anti- penta-His tag monoclonal antibody, detected with horseradish
peroxidase-conjugated goat anti-mouse antibody. B)
Immunofluorescence analysis of recombinant scFvs, recombinant N
protein expressing SF9 cells were fixed on dot slides, incubated
with scFvs, (1) 76-118 N incubate with L13F scFv; (2) L99 N incubate
with L13F scFv; (3) 76-118 N incubate with H34 scFv; (4) L99 N
incubate with H34 scFv. C) Intracellular localization of scFvs. COS-7
cells were seeded onto a 6-well plate, grown to 80% confluency,
and transfected with intracellular antibodies expressing plasmid (1)
L13F3-scFv-CYTO; (2) H34-scFv-CYTO; (3) L13F3-scFv-ER and (4) H34-
scFv-ER. The cells were fixed at 48 h posttransfection, and the scFvs
was identified with IFA by using anti-His MAb, images were
obtained with confocal microscope with 100 × objectives.
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body, did not pull-down the N protein of Seoul L99
virus, as expected (Figure2 A ,l a n e8 ) .Np r o t e i na n d
scFvs were not found in either negative or blank con-
trols (Figure 2A, lanes 3 and 5). These observations
were confirmed by detection with either anti-N protein
mAb (Figure 2B) or anti-His mAb (Figure 2C) in immu-
noblot assays. Therefore, N protein and the N protein-
specific scFvs likely specifically interact in vivo.
3.3. Hantavirus N protein co-localized with intracellular
antibodies
Intracellular localization of N p r o t e i ni nt r a n s i e n t l yc o -
transfected COS-7 cells or virus infected Vero-E6 cells
containing intracellular antibodies was determined
under a confocal microscope. The recombinant N pro-
tein of HTNV strain 76-118 co-localized with intracellu-
lar L13F3 and H34 scFvs in both the ER and cytoplasm
in COS-7 cells (Figure 3A). In contrast, the cytoplasmi-
cally expressed scFv did not co-localize with Gc protein
of HTNV strain 76-118, but the ER-specific scFvs
showed partial co-localization (Figure 3B). The N pro-
tein of HTNV strain 76-118 also co-localized with scFvs
in Vero-E6 cell lines with L13F3-ER, L13F3-CYTO,
H34-ER, and H34-CYTO antibodies, and L99 viral N
protein co-localized only with L13F3 derived intracellu-
lar antibodies (Figure 3C).
3.4. Inhibition of N protein trafficking reduced HTNV
replication
To determine the effect of intracellular antibodies on
hantavirus replication, stably transfected L13F3-scFv-ER-
E6, H34-scFv-ER-E6, L13F3-scFv-Cyto-E6, and H34-
scFv-Cyto-E6 cell lines (1 × 10
6) were infected with
HTNV strain 76-118 and SEOV strain L99 at a MOI of
0.01. Cell culture supernatants were collected each day
after the third day postinfection and viral antigen loads
were determined by ELISA. Data suggested that HTNV
N protein antigen levels in L13F3-scFv-ER-E6 and
L13F3-scFv-Cyto-E6 cell lines were lower than that of
control cells (Figure 4A). In contrast, N protein antigen
levels in stably transfected H34-scFv-ER-E6 and H34-
scFv-Cyto-E6 cell lines decreased only when infected
with HTNV strain 76-118, but not with SEOV strain L99
(Figure 4B). These data correlate with the antigen-bind-
ing specificities of the antibodies. No significant differ-
ence of virus replication was observed between stably
transfected cell lines and normal non-transfected Vero
E6 cells when intracellular antibodies were not specific
for the infecting virus. This indicates that intracellular
antibodies did not have a negative effect on cell growth,
since the SEOV replication rate in H34 antibody-expres-
sing cell lines was similar to that in control Vero E6 cells.
HTNV levels in supernatants from the sixth day postin-
fection were titrated via TCID50 assay. Titers correlated
with N protein antigen levels as determined by ELISA
(Figure 5). These data indicate that both ER- and cyto-
plasm-targeted scFv antibodies inhibited HTNV replica-
tion. However, HTNV type-specific H34 antibody did not
significantly affect replication of SEOV strain L99.
4. Discussion
In this study, we demonstrated that N protein of Hantaan
and Seoul virus localizes to the ER/cis-Golgi in the
a b s e n c eo fm e m b r a n eg l y c o p r o t e i n s .D a t af u r t h e rs u g -
gested that N protein co-localized with intracellular anti-
bodies with the ER retention marker SEKDEL. In
addition, analysis of antibody-expressing cell lines,
infected with viruses, revealed that N protein trafficking
to the ER/cis-Golgi is important for viral replication.
Blocking of N protein trafficking at both the ER/cis-Golgi
and in the cytosol leads to inhibition of replication.
The N protein is a 420-430 residue 50-kDa protein,
the N-terminal 75 residues of which carry two coiled-
coil motifs that facilitate trimerization and nucleocapsid
Figure 2 His-tag pull-down assay between intracellular scFvs
and hantavirus N protein. Stably transfected Vero E6 cells,
indicated as L13F3-scFv-ER and H34-scFv-ER, were infected
with hantavirus 76-118 and L99 respectively. About 5 × 10
7
infected cells were collected and cell extracts incubated with
Ni-NTA His-bind resin. After washing, bound proteins were eluted
and concentrated by adding two volumes of ice-cold 100% ethanol
and centrifuged at 10,000 × g for 10 min. Pellets were resuspended
in 10 μl distilled water and analyzed by SDS-PAGE (A), Intracellular
scFvs were analysized by immunoblotting with anti-penta-HIS
(Qiagen) (B), and N proteins were blotted by N protein-specific
mAbs L13F3 (C).
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COS-7 cells were co-transfected with pEF-N76118 and a intracellular scFv expressing plasmid [(I) L13F3 scFv-CYTO, (II) H34-scFv-CYTO, (III) L13F3-
scFv-ER, (IV) H34-scFv-ER], 2 days post transfection, slides were acetone fixed, and costained with human anti-N IgG H34 [green, panels 1] or anti-
penda-His mAb [red, panels 2]), merged images of the panels 1 and 2 are presented in panels 3; B) Co-localization of Gc with intracellular scFvs,
Stably transfected vero E6 cells [(I) L13F3 scFv-CYTO, (II) H34-scFv-CYTO, (III) L13F3-scFv-ER, (IV) H34-scFv-ER] were infected with 76-118 at an MOI
of 0.1, and after 6 days slides were acetone fixed, and costained with anti-Gc mAb AH100 [green, panels 1] or anti-N mAb [red, panels 2]),
merged images of the panels 1 and 2 are presented in panels 3. C) Co-localization of viral N protein with intracellular scFvs. Intracellular scFv
stably transfected vero E6 cells were infected with 76-118 at an MOI of 0.01, [(I) L13F3 scFv-CYTO, (II) H34-scFv-CYTO, (III) L13F3-scFv-ER, (IV) H34-
scFv-ER], or with L99 at an MOI of 0.01 [(V) L13F3 scFv-CYTO, (VI) L13F3-scFv-ER], and after 5-6 days slides were acetone fixed, and costained with
human anti-N mAb AH34 [green, panels 1] or mouse anti-His tag mAb [red, panels 2]), merged images of the panels 1 and 2 are presented in
panels 3. Excitation wavelengths were 488 and 568 nm; Fluorescence images were obtained with confocal microscope using 100 × objectives.
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assembly intermediates [10,11]. The L13F3 scFv anti-
body used in this study is known to bind to the N term-
inal 30 residues of N protein, which comprises part of
the first coiled-coil motif [11]. Additionally, H34 scFv
has been shown to bind to a conformational epitope.
In hantaviruses, N protein is the first viral protein to
accumulate during infection [13,19,20]. Viral RNA seg-
ments are complexed with N protein to form individual
L, M, and S nucleocapsids [1], which are then packaged
into the virion at the bilayered envelope within which
are embedded the two viral surface glycoproteins Gn
and Gc [21]. The specific interaction between N protein
and glycoprotein is thought to trigger budding of virions
into the Golgi cisternae and to initiate the virus assem-
bly [4,5]. Although the laboratory evidences were pre-
sented recently, the precise mechanism of N protein
entry into the ER/cis-Golgi apparatus remains unclear.
ER-targeted scFvs used for tracking N protein intracellu-
lar trafficking were combined with a SEKDEL sequence
at the carboxyl terminus. In mammalian cells, SEKDEL
receptors are localized primarily to the early Golgi com-
plex at steady state [22,23], but shift in their localization
upon binding of SEKDEL-bearing ligands [24]. There-
fore, we predicted that the ER-targeted scFvs would fol-
low a route from the ER to the cis-Golgi and retrograde
transport back to the ER. The co-localization and the
proved interaction of N and ER-targeted intracellular
antibodies indicate that N protein may entry into the
ER/cis-Golgi apparatus. During virus infection, N pro-
tein or nucleocapsids also co-localized with ER-targeted
antibodies. Virus replication was inhibited by the ER-
targeted antibodies, which implies that N protein or
nucleocapsids presented in membrane cisternae at the
ER/cis-Golgi apparatus. Previous studies have shown
that N protein is membrane-associated [9,14], and that
both targeting of N to ERGIC prior to its movement to
the Golgi compartment and an intact ERGIC were
required for viral replication [14]. In membrane subcel-
lular fractionation experiments, a small proportion of
total N protein was detected in membrane-containing
fractions [14]. We hypothesize that N protein enters the
ER or cis-Golgi apparatus, but only with low efficiency.
An interaction between ER-targeted scFvs and mem-
brane-associated N protein may act as a “motor” to
enhance the entry of N protein into ER/cis-Golgi mem-
brane vesicles. Like the function of the interaction of N
protein and the cytoplasmic tail of Gn/Gc during virus
replication [4,5]. The ER provides a lower-energy envir-
onment than the Golgi system [25], which might
enhance the entry of cytosol protein or nucleocapsids.
The interaction between N and G protein is not the
only prerequisite for the entry of N protein or cytosol
nucleocapsids into membrane vesicles. Antibodies or
other molecules might be alternative driver to direct the
N protein to membrane vesicles. Immunoelectron
microscopy examination of Uukuniemi virus, a bunya-
virus, also demonstrated that the nucleocapsid is
Figure 4 Hantavirus N protein levels in supernatants of virus
infected cell lines determined by ELISA. (A) Infected with HTNV
strain 76-118 and (B) infected with SEOV strain L99. Mouse anti-N
mAb L13F3 was coated onto 96-well microtiter plates; detergent-
treated culture supernatants were loaded and N protein was
detected by horseradish peroxidase-conjugated anti-HTNV L13F3
mAb. Error bars represent the standard deviation of three
independent experiments.
Figure 5 Titration of viral load in cell culture supernatants by
TCID50 assay. Intracellular antibody-expressing stable cell lines
were infected with hantavirus 76-118 and L99 respectively; virus titer
at sixth day post infection was determined by the TCID50 assay.
Endpoint was determined on day 10, cells fixed on the bottom of
the culture plate by 80% (v/v) ice-cold acetone. Viral antigen were
detected by horseradish peroxidase conjugated L13F3 monoclonal
antibody, virus infection was assessed by absorbance at 450 nm
(reference 620 nm). Error bars represent the standard deviation of
three independent experiments.
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distribution and tubulovesicular morphology of the pre-
Golgi intermediate compartment, suggesting that the
first site of formation of Uukuniemi virus particles is the
pre-Golgi intermediate compartment and that virus bud-
ding continues in the Golgi stack [26].
In summary, the data we present in this study suggest
that N protein may present in the ER/cis-Golgi without
the assistance of viral G protein, and that N protein traf-
ficking at these sites plays an important role in HTNV
replication.
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